ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)

ImmuneOncia Therapeutics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	16,559	8,226	20,957	26,730	36,320	12,027
Short-Term Investments	15,100	3,100	5,000	-	6,000	8,708
Cash & Short-Term Investments	31,659	11,326	25,957	26,730	42,320	20,735
Cash Growth	21.97%	-56.36%	-2.89%	-36.84%	104.10%	-23.41%
Accounts Receivable	-	421.83	11	633.65	-	-
Other Receivables	765.42	7,709	172.13	202.16	41.53	49.3
Receivables	765.42	8,131	183.13	835.81	41.53	49.3
Prepaid Expenses	3,151	297.34	376.95	520.18	232.62	98.18
Other Current Assets	487.36	107.93	118.97	884.02	72.89	38.05
Total Current Assets	36,063	19,863	26,636	28,970	42,667	20,920
Property, Plant & Equipment	462.84	494.54	892.1	547.33	997.96	835.55
Other Intangible Assets	4,617	4,908	5,429	5,987	6,503	7,064
Other Long-Term Assets	1,497	930.02	838.32	188.36	932.89	175.63
Total Assets	42,639	26,195	33,795	35,693	51,101	28,996
Accrued Expenses	137.63	137.63	103.34	154.4	128.24	214.87
Current Portion of Leases	58.06	51.05	50.11	98.69	216.39	76.78
Current Unearned Revenue	1,950	1,950	1,950	1,950	6,902	18.62
Other Current Liabilities	2,262	4,354	1,268	1,646	1,578	1,262
Total Current Liabilities	4,408	6,493	3,372	3,850	8,824	1,572
Long-Term Leases	25.09	44.01	86.83	24.27	98.24	24.47
Pension & Post-Retirement Benefits	127.82	15.06	14.27	-	184.09	-
Other Long-Term Liabilities	282.42	219.18	236.63	84,226	101,526	52,929
Total Liabilities	4,843	6,771	3,710	88,100	110,633	54,526
Common Stock	37,550	36,365	26,896	26,141	25,503	23,128
Additional Paid-In Capital	114,758	79,021	35,292	28,046	22,148	-
Retained Earnings	-128,717	-110,721	-105,016	-113,921	-110,518	-50,045
Comprehensive Income & Other	14,205	14,759	8,637	7,326	3,336	1,387
Total Common Equity	37,796	19,424	-34,192	-52,407	-59,532	-25,530
Shareholders' Equity	37,796	19,424	30,086	-52,407	-59,532	-25,530
Total Liabilities & Equity	42,639	26,195	33,795	35,693	51,101	28,996
Total Debt	83.14	95.06	136.94	122.97	314.63	101.26
Net Cash (Debt)	31,576	11,231	25,820	26,607	42,005	20,633
Net Cash Growth	22.29%	-56.50%	-2.96%	-36.66%	103.58%	-23.17%
Net Cash Per Share	472.03	199.46	492.28	510.53	904.13	4461.02
Filing Date Shares Outstanding	74.08	56.31	52.45	52.12	46.46	4.63
Total Common Shares Outstanding	74.08	56.31	52.45	52.12	46.46	4.63
Working Capital	31,655	13,370	23,264	25,120	33,842	19,348
Book Value Per Share	510.20	344.97	-651.90	-1005.59	-1281.39	-5519.70
Tangible Book Value	33,180	14,516	-39,621	-58,394	-66,035	-32,594
Tangible Book Value Per Share	447.88	257.81	-755.41	-1120.48	-1421.36	-7047.03
Machinery	1,346	1,514	1,443	1,173	1,148	1,053

Source: S&P Global Market Intelligence. Standard template. Financial Sources.